NightHawk Biosciences, Inc.
AMEX:NHWK
0.4416 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.981 | 2.113 | 2.948 | 3.049 | 5.794 | 1.52 | 0.342 | 0 | 0 | 0 | 0.003 | 0.188 |
| Cost of Revenue
| 6.401 | 0.691 | 12.939 | 13.014 | 16.233 | 8.268 | 9.331 | 0.116 | 5.248 | 1.397 | 0.253 | 0 |
| Gross Profit
| -0.42 | 1.421 | -9.991 | -9.965 | -10.439 | -6.748 | -8.989 | -0.116 | -5.248 | -1.397 | -0.25 | 0.188 |
| Gross Profit Ratio
| -0.07 | 0.673 | -3.389 | -3.268 | -1.802 | -4.439 | -26.311 | 0 | 0 | 0 | -80.411 | 1 |
| Reseach & Development Expenses
| 23.461 | 18.821 | 12.939 | 13.014 | 16.233 | 8.268 | 9.331 | 2.595 | 2.861 | 2.738 | 0.903 | 1.247 |
| General & Administrative Expenses
| 21.131 | 16.828 | 14.934 | 9.431 | 7.025 | 6,370.954 | 4.138 | 4.356 | 3.978 | 2,429.796 | 1.184 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | -6,364.583 | 0 | 14.071 | 5.348 | -2,425.969 | 0.006 | 0 |
| SG&A
| 21.131 | 16.828 | 14.934 | 9.431 | 7.025 | 6.371 | 4.138 | 18.427 | 9.326 | 3.827 | 1.443 | 0.976 |
| Other Expenses
| 0.628 | -0.966 | 0.188 | -0.026 | 0.118 | 224.289 | 0.671 | 14.071 | 5.348 | 1,397.157 | 0 | 0 |
| Operating Expenses
| 45.221 | 35.65 | 27.873 | 22.445 | 23.258 | 14.639 | 13.469 | 21.022 | 12.187 | 6.565 | 2.346 | 2.223 |
| Operating Income
| -45.689 | -35.419 | -26.124 | -20.746 | -17.96 | -13.343 | -13.127 | -21.022 | -12.187 | -6.565 | -2.343 | -2.035 |
| Operating Income Ratio
| -7.639 | -16.764 | -8.862 | -6.804 | -3.1 | -8.779 | -38.424 | 0 | 0 | 0 | -753.272 | -10.836 |
| Total Other Income Expenses Net
| -1.51 | -4.376 | -1.456 | -0.944 | -0.112 | -0.701 | 0.153 | -0.1 | -0.056 | -0.045 | -0.108 | -0.064 |
| Income Before Tax
| -47.151 | -35.547 | -26.381 | -20.34 | -17.577 | -13.219 | -12.975 | -21.122 | -12.243 | -6.61 | -2.451 | -2.099 |
| Income Before Tax Ratio
| -7.883 | -16.824 | -8.949 | -6.671 | -3.034 | -8.697 | -37.978 | 0 | 0 | 0 | -788.109 | -11.177 |
| Income Tax Expense
| -3.289 | -0.146 | 1.313 | 0.045 | -0.985 | -0.81 | 0.819 | -0.463 | -0.381 | 2.181 | 0.07 | 0.069 |
| Net Income
| -43.862 | -35.401 | -27.694 | -20.385 | -15.734 | -11.842 | -12.574 | -20.295 | -11.789 | -8.711 | -2.42 | -2.105 |
| Net Income Ratio
| -7.334 | -16.755 | -9.394 | -6.685 | -2.716 | -7.791 | -36.804 | 0 | 0 | 0 | -778.199 | -11.209 |
| EPS
| -1.72 | -1.42 | -1.73 | -4.29 | -6.3 | -21.56 | -50.05 | -177.23 | -127.84 | -162.73 | -92.49 | -79.03 |
| EPS Diluted
| -1.71 | -1.42 | -1.73 | -4.29 | -6.3 | -21.56 | -50.05 | -174.92 | -126.18 | -160.61 | -91.28 | -79.03 |
| EBITDA
| -40.757 | -31.069 | -22.381 | -18.045 | -16.731 | -12.962 | -12.293 | -20.84 | -12.079 | -6.548 | -2.34 | -2.034 |
| EBITDA Ratio
| -6.814 | -14.705 | -7.592 | -5.918 | -2.888 | -8.528 | -35.983 | 0 | 0 | 0 | -752.44 | -10.83 |